Skip to main content

Advertisement

Log in

Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer

  • Research Paper
  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Chemokines promote tumour progression by enhancing proliferation and modifying the immune response. The purpose of this study was to test the hypothesis that CCL2 monocyte chemotactic protein-1 (MCP-1) contributes to the progression of colorectal cancer by influencing the number and distribution of tumour associated macrophages (TAMs). Chemokine expression was assessed in human colorectal adenocarcinomas by ribonuclease protection assay (RPA). Colonic adenocarcinoma cell lines were used to assess chemokine production by enzyme linked immunosorbant assay (ELISA), and Boyden microchemotaxis assays were performed to determine cell line supernatant monocyte chemotactic activity. CCL2 production was assessed in paraffin embedded tumour samples by immunohistochemistry. Finally, the number of macrophages and their distribution was determined in the same colorectal adenocarcinomas and compared with CCL2 expression and tumour stage. Results showed that CCL2 produced by cell lines induced monocyte chemoattraction, the expression of this chemokine in solid cancers increased with tumour stage (P < 0.05) and immunohistochemistry localized production to tumour cells. Analysis of the macrophage infiltrate showed that the accumulation was significantly greater in tumours than controls (P < 0.005) and within tumours it was greatest in necrotic regions (median 44,600 per mm3). Macrophage accumulation increased with tumour stage and correlated with CCL2 expression (r s = 0.8). CXCL8 interleukin 8 (IL-8), a potent angiogenic factor and growth factor, was expressed in all tumours and cell lines. It is concluded that CCL2 induces the accumulation of tumour promoting TAMs in human colorectal cancer and represents a therapeutic target to modify the macrophage response and direct immune mediated therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

ATP:

Adenosine triphosphate

DAB:

Diaminobenzidine

ELISA:

Enzyme linked immunosorbant assay

FBS:

Fetal bovine serum

GAPDH:

Glyceraldehyde-3-phosphate dehydrogenase

IL-8:

Interleukin 8

IP-10:

Interferon inducible protein 10

Ltn:

Lymphotactin

mAb:

Monoclonal antibody

MCP-1:

Monocyte chemotactic protein-1

MIP-1α:

Macrophage inflammatory protein 1 alpha

MIP-1β:

Macrophage inflammatory protein 1 beta

MMP-9:

Matrix metalloproteinase-9

PBS:

Phosphate buffered saline

RANTES:

Regulated on activation normal T-cell expressed and secreted

RPA:

Ribonuclease protection assay

SE:

Standard error

TAM:

Tumour associated macrophage

TBE:

Tris-borate buffer

TNFα:

Tumour necrosis factor α

UTP:

Uridine-5′-triphosphate

VEGF:

Vascular endothelial growth factor

References

  1. IUS/WHO subcommittee on chemokine nomenclature (2002) Chemokine/chemokine receptor nomenclature. J Interferon Cytokine Res 22:1067–1068

    Article  Google Scholar 

  2. Rossi D, Zlotnik A (2000) The biology of chemokines and their receptors. Annu Rev Immunol 18:217–242

    Article  PubMed  CAS  Google Scholar 

  3. Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12:121–127

    Article  PubMed  CAS  Google Scholar 

  4. Larsen CG, Anderson AO, Appella E et al (1989) The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243:1464–1466

    Article  PubMed  CAS  Google Scholar 

  5. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539–545

    Article  PubMed  CAS  Google Scholar 

  6. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867

    Article  PubMed  CAS  Google Scholar 

  7. Balkwill F (2003) Chemokine biology in cancer. Semin Immunol 15:49–55

    Article  PubMed  CAS  Google Scholar 

  8. Burke F, Relf MG, Negus RPM et al (1996) A cytokine profile of normal and malignant ovary. Cytokine 8:578–585

    Article  PubMed  CAS  Google Scholar 

  9. Rollins BJ (2006) Inflammatory chemokines in cancer growth and progression. Eur J Cancer 42:760–767

    Article  PubMed  CAS  Google Scholar 

  10. Negus RPM, Stamp GWH, Relf MG et al (1995) The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest 95:2391–2396

    PubMed  CAS  Google Scholar 

  11. Luboshits G, Shina S, Kaplan O et al (1999) Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res 59:4681–4687

    PubMed  CAS  Google Scholar 

  12. Saji H, Koike M, Yamori T et al (2001) Significant correlation of monocyte chemoattractant protein-1 expression with neovascularisation and progression of breast carcinoma. Cancer 92:1085–1091

    Article  PubMed  CAS  Google Scholar 

  13. Negus RPM, Stamp GWH, Hadley J, Balkwill FR (1997) A quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am J Pathol 150:1723–1734

    PubMed  CAS  Google Scholar 

  14. Ueno T, Toi M, Saji H, Muta M et al (2000). Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 6:3282–3289

    PubMed  CAS  Google Scholar 

  15. Mantovani A, Bottazi B, Colotta F et al (1992) The origin and function of tumour-associated macrophages. Immunol Today 13:265–270

    Article  PubMed  CAS  Google Scholar 

  16. Mantovani A, Ming WA, Balotta C, Abdeljalil B et al (1986) Origin and regulation of tumor-associated macrophages: the role of tumor-derived chemotactic factor. Biochem Biophys Acta 865:59–67

    PubMed  CAS  Google Scholar 

  17. Barbera-Guillem E, Nyhus J.K, Wolford CC et al (2002) Vascular endothelial growth factor secretion by tumour-infiltrating macrophages essentially supports tumour angiogenesis, and IgG immune complexes potentiate the process. Cancer Res 62:7042–7049

    PubMed  CAS  Google Scholar 

  18. Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66:605–612

    Article  PubMed  CAS  Google Scholar 

  19. Sica A, Schioppa T, Mantovani A et al (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42:717–727

    Article  PubMed  CAS  Google Scholar 

  20. Rollins BJ (1997) Chemokines. Blood 90:909–928

    PubMed  CAS  Google Scholar 

  21. Tsuchiya S, Yamabe M, Yamaguchi Y et al (1980) Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 26:171–176

    Article  PubMed  CAS  Google Scholar 

  22. Curtis ASG (1960) Area and volume measurements by random sampling methods. Med Biol Illus 10:261–266

    PubMed  CAS  Google Scholar 

  23. Dehoff RT, Rhines FN (1961) Determination of the number of particles per unit volume from measurements made on random plane sections: the general cylinder and ellipsoid. Trans Am Inst Mining Metallurg Eng 221: 975

    CAS  Google Scholar 

  24. Aherne WA, Dunhill MS (1982) Morphometry. Arnold, London

    Google Scholar 

  25. Kolios G, Wright K, Jordan N et al (1999) C-X-C and C-C chemokine expression and secretion by the human colonic epithelial cell line, HT-29: differential effect of T lymphocyte-derived cytokines. Eur J Immunol 29:530–536

    Article  PubMed  CAS  Google Scholar 

  26. Banner BF, Savas L, Baker S et al (1993). Characterization of the inflammatory cell populations in normal colon and colonic carcinomas. Virchows Arch B Cell Pathol 64:213–220

    Article  CAS  Google Scholar 

  27. Fidler IJ, Schroit AJ (1984) Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases. J Immunol 133:515–518

    PubMed  CAS  Google Scholar 

  28. Mantovani A (1994) Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab Invest 71:5–16

    PubMed  CAS  Google Scholar 

  29. Huang S, Van Arsdall M, Tedjarati S et al (2002) Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 94:1134–1142

    PubMed  CAS  Google Scholar 

  30. Bingle L, Lewis CE, Corke K et al (2006) Macrophages promote angiogenesis in human breast tumour spheroids in vivo. Br J Cancer 94:101–107

    Article  PubMed  CAS  Google Scholar 

  31. Tsutsui S, Yasuda K, Suzuki K et al (2005) Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 14:425–431

    PubMed  CAS  Google Scholar 

  32. Ohno S, Ohno Y, Suzuki N et al (2004) Correlation of histological localization of tumour-associated macrophages with clinicopathological features in endometrial cancer. Anticancer Res 24:3335–3342

    PubMed  Google Scholar 

  33. Hanada T, Nakagawa M, Emoto A et al (2000) Prognostic value of tumour-associated macrophage count in human bladder cancer. Int J Urol 7:263–269

    Article  PubMed  CAS  Google Scholar 

  34. Funada Y, Noguchi T, Kikuchi R et al (2003) Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer. Oncol Rep 10:309–313

    PubMed  Google Scholar 

  35. Negus RP, Turner L, Burke F et al (1998) Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumours. J Leukoc Biol 63:758–765

    PubMed  CAS  Google Scholar 

  36. Salcedo R, Ponce ML, Young HA et al (2000) Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumour progression. Blood 96:34–40

    PubMed  CAS  Google Scholar 

  37. Scotton CJ, Wilson JL, Milliken D et al (2001) Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res 61:4961–4965

    PubMed  CAS  Google Scholar 

  38. Brew R, Erikson JS, West DC et al (2000) Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 12:78–85

    Article  PubMed  CAS  Google Scholar 

  39. Ueda T, Shimada E, Urakawa T (1994) Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis. J Gastroenterol 29:423–429

    Article  PubMed  CAS  Google Scholar 

  40. Griffiths L, Binley K, Iqball S et al (2000) The macrophage—a novel system to deliver gene therapy to pathological hypoxia. Gene Ther 7:255–262

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Supported by grants from The Foyle Foundation and The Royal College of Surgeons of England. We are very grateful to Professor F Balkwill and Dr M Grimshaw, Cancer Research UK Translational Oncology Laboratory, London, for their assistance with this work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Charles Bailey.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bailey, C., Negus, R., Morris, A. et al. Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer. Clin Exp Metastasis 24, 121–130 (2007). https://doi.org/10.1007/s10585-007-9060-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10585-007-9060-3

Keywords

Navigation